The First Annual China Cell Culture Engineering And Technology Conference Was Successfully Held

Nov 22, 2021

Leave a message

The first China Cell Culture Engineering and Technology (CCET) Academic Conference was held in Shanghai on December 15, 2021, with the support of the Chinese Society of Biological Engineering. The conference is organized by Prof. Tan Wensong's team at the State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, and co-organized by BioEngine to promote the discipline development, scientific research, and talent cultivation in the field of cell culture engineering and technology in China, and to strengthen the cooperation and communication between industry, academia, research and application parties. The conference was opened by Prof. Tan Wensong, and Prof. Zhang Hongxiang, Secretary General of the Chinese Society of Biological Engineering, sent a message by video.

 

1640153207426487.jpg

1640153214120303.png

Video message from Prof. Zhang Hongxiang, Secretary General of the Chinese Society of Biological Engineering

 

This year's conference focused on key scientific issues and engineering application technologies of biopharmaceutical R&D and industrialization of antibodies, recombinant proteins, virus vaccines, stem cells/cell therapy, etc. Top experts from universities and enterprises in the field of cell culture engineering and technology at home and abroad were invited to attend and share their cutting-edge academic and application research.

1640153264437245.jpg

Dr. Wensong Tan, Professor at East China University of Science and Technology and Founder of BioEngine

news-500-333

Professor Wei-Shou Hu, University of Minnesota, USA

1640153445970409.jpg

Dr. Wei-Chang Zhou, Chief Technology Officer and Executive Vice President of WuXi Biologics

news-1600-1066

Professor Jianwei Zhu, Dean of the School of Pharmacy, Shanghai Jiao Tong University

1640153902973551.jpg

Dr. Yue Han, Director of Project Management and Corporate Development, Hanten Bio

news-1600-1066

Dr. Hui Feng, Chief Operating Officer, Junshi Biologics

news-1600-1066

Dr. Shuyuan Yao, Chief Executive Officer, Anovalu Pharmaceuticals (Shanghai) Co.

Dr. Xuping Liu, President, and Dr. Liang Zhao, Vice President of BioEngine, also presented "Cell culture-based vaccine industrial production" and "Artificial intelligence-assisted animal cell culture and process development strategy thinking and practice", respectively.

1640154496593107.jpg

Dr. Xuping Liu, President of BioEngine

news-500-333

 

Dr. Zhao Liang, Associate Researcher at East China University of Science and Technology and Vice President of BioEngine

 

As Prof. Zhang Hongxiang mentioned in his speech, biotechnology is identified as one of the seven frontier areas of scientific and technological research in China's 14th Five-Year Plan and 2035 Visionary Goals to strengthen national strategic scientific and technological forces and enhance original and leading scientific and technological research. The first CCET Annual Academic Conference was held to build a platform for exchange and discussion between academia and industry for China's antibody, vaccine, and cell therapy industries, and to solidify the foundation for healthy and rapid development of the industry.

As the initiator of the annual academic conference, Prof. Tan Wensong shared the initial intention of holding the annual conference on cell culture engineering and technology in China. He said that the annual cell culture engineering conferences were established in Europe, the United States, and Japan as early as the 1980s, providing a good communication platform for the global cell culture engineering academic and industrial communities. It not only focuses on key scientific issues and engineering application technologies in cell culture, but also builds a platform for communication and discussion between domestic academia and industry, promotes interaction and cooperation between industry, academia, research, and application, and also aims directly at the international frontier, participates in international exchange, and enhances the development of disciplines, scientific research and personnel training. It also directly aims at the international frontier, participates in international exchange, and enhances discipline development, scientific research, and talent cultivation.

 

1640154538184606.jpg

The atmosphere at the meeting was warm, and the participants expressed that the CCET Annual Conference was of high specifications and full of dry goods shared by the guests, and they were looking forward to the second CCET.

Send Inquiry

Provide high quality culture media for research institutions, biopharmaceutical companies and clinical trial institutions, etc.

I agree to receive other communications from BioEngine which may contain technical or marketing information from this organization. You can unsubscribe from these communications at any time.
By submitting this form, you are agreeing to the terms and conditions of our Privacy Policy

Professional Cell Culture Solutions for Biopharmaceutical Development

Our expert scientific team delivers end-to-end cell culture services to support your biopharmaceutical production needs. We provide comprehensive solutions including:
- Process development & optimization
- Customized medium formulation design
- Scalable medium processing & GMP manufacturing

For technical inquiries or service requests, please submit your message through our [Quick Message] portal. Our specialists will respond within 24 business hours.

For urgent matters, please contact +86 137 5514 6322 directly